Sana Biotech stock jumps on cell therapy data (SANA:NASDAQ)

Jan 8, 2025 · Sana Biotechnology (SANA) stock soared after Phase 1 data for its cell therapy which, according to Morgan Stanley, has de-risked its HIP platform. Read more here.

36%
OFF

Sana Biotechnology’s (SANA) Revolutionary Breakthrough Sends …

2 weeks from now

Jan 8, 2025 · The +256.36% jump in stock price highlights the market’s enthusiastic reaction to the potential of Sana’s HIP-modified cell therapy. When comparing Sana’s stock to broader …

bovnews.com

$75
OFF

Sana’s Stock Soars On New Cell Therapy Data; UniQure’s $75M Offering

2 weeks from now

Jan 8, 2025 · Biotech updates: Sana stock soars on diabetes therapy data, UniQure's offering, BioInvent's lymphoma success, Alpha's Zunveyl deal, Neumirna funding, and Cassava's layoffs.

endpts.com

275%
OFF

SANA Stock Price | Sana Biotechnology Inc. Stock Quote (U.S.: …

2 weeks from now

6 days ago · SANA | Complete Sana Biotechnology Inc. stock news by MarketWatch. ... Sana Biotechnology Gets FDA Fast Track Designation for SC291 Cell Therapy ... Sana jumps 275% …

marketwatch.com

152%
OFF

SANA Stock Surges 152% In A Week On Upbeat Initial Diabetes …

2 weeks from now

6 days ago · Sana stock soars in a week following positive initial data from a first-in-human study of investigational cell therapy, UP421, in diabetes patients.

zacks.com

3%
OFF

SANA News Today | Why Did Sana Biotechnology Stock Go Up

2 weeks from now

Jan 8, 2025 · Fmr LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 16.3% in the third quarter, according to the company in its most recent Form 13F …

marketbeat.com

400%
OFF

Sana Biotechnology (NASDAQ:SANA) Soars 400% On …

2 weeks from now

Jan 8, 2025 · Sana Biotechnology (SANA) stock soared after the company announced what it believes is a world-first breakthrough for type-1 diabetes treatments. Stay Ahead of the …

nasdaq.com

152%
OFF

SANA Stock Surges 152% In A Week On Upbeat Initial Diabetes …

2 weeks from now

5 days ago · Shares of Sana Biotechnology SANA skyrocketed 151.5% in the past week after the company announced positive initial results from a potentially groundbreaking type 1 diabetes …

nasdaq.com

105%
OFF

Sana Bio (SANA) Stock Rallies 105% In 3 Months: Here's Why

2 weeks from now

Jan 18, 2024 · Sana Biotechnology, Inc. Price and Consensus. Sana Biotechnology, Inc. price-consensus-chart | Sana Biotechnology, Inc. Quote. Zacks Rank and Other Stocks to Consider. …

nasdaq.com

274%
OFF

Citi Keeps $15 Target On Sana, Says Data ... - Markets Insider

2 weeks from now

Jan 8, 2025 · The firm anticipates the stock could continue to appreciate after the open today and keeps a Buy rating on the name with a $15 price target Sana in premarket trading is up 274%, …

businessinsider.com

265%
OFF

Sana Biotechnology Shares Spike Following Successful …

2 weeks from now

Jan 7, 2025 · The stock more than tripled, up 265% to $6.02, in after-hours trading Tuesday. Shares ended the regular session 5.7% lower, at $1.65, putting them down 68% in the last 52 …

marketwatch.com

300%
OFF

This Biotech Stock Soared 300% Overnight. Why It Can Go Higher.

2 weeks from now

Jan 8, 2025 · Sana Biotechnology shares are at about $5 now, and strategists see a chance they could go to $10.

barrons.com

201%
OFF

Sana Soars On Favorable Type 1 Diabetes Phase I Data

2 weeks from now

Jan 8, 2025 · A preview of the next edition of BioWorld, Jan. 8, 2025. Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results …

bioworld.com

250%
OFF

Sana Biotechnology (SANA), EBay (EBAY) Are Among Today’s Big …

2 weeks from now

Jan 8, 2025 · Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market’s losses. Sana is soaring nearly 250%, while eBay is climbing a …

yahoo.com

$12
OFF

Sana Biotechnology Price Target Raised To $12 From $9 At Morgan …

2 weeks from now

4 days ago · Morgan Stanley raised the firm’s price target on Sana Biotechnology (SANA) to $12 from $9 and keeps an Overweight rating on the shares. Based on the recent type one diabetes …

businessinsider.com

$588
OFF

Cell Therapy Biotech Sana Biotechnology Prices Further Upsized

2 weeks from now

Feb 4, 2021 · Sana Biotechnology, a preclinical biotech developing engineered cell therapies for multiple indications, raised $588 million by offering 23.5 million shares at $25, above upwardly …

nasdaq.com

FAQs about Sana Biotech stock jumps on cell therapy data (SANA:NASDAQ) Coupon?

Why did Sana biotechnology stock soared after Phase 1 data?

Sana Biotechnology (SANA) stock soared after Phase 1 data for its cell therapy which, according to Morgan Stanley, has de-risked its HIP platform. Read more here. ...

Is Sana biotechnology (Sana) a good stock to buy?

Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market's losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%. Sana Reports Upbeat Trial ResultsSana announced that its primary islet cell therapy, UP421, had been successfully implanted into a Type 1 diabetes patient. ...

Why did Sana biotechnology (Sana) rise 200%?

Sana Biotechnology (NASDAQ: SANA) climbed over 200% on Wednesday following a sharp rally in the post-market yesterday in reaction to a Phase 1 readout for its UP421 cell therapy, which, according to Morgan Stanley, has de-risked the company's hypoimmune (HIP) therapeutic platform. ...

Where is Sana Biotechnology Inc headquartered?

The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA. SANA | Complete Sana Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Is Sana biotechnology's'reward' worth it?

Citi says that while the wait for Sana Biotechnology’s (SANA) initial type 1 diabetes data was long, the “reward was well worth it as Sana has delivered what looks to be potentially transformative data,” the analyst tells investors in a research note. ...

What is Sana biotechnology sc291?

Sana Biotechnology, Inc., a company focused on changing the possible for patients through engineered cells, today announced it will prioritize future development activity for SC291, the company’ s CD19-directed allogeneic CAR T cell therapy, in B-cell mediated autoimmune diseases. ...